Patent ID: 11884645
Assignee: INFLAZOME LIMITED
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 3:
4. The compound or the pharmaceutically acceptable salt or solvate thereof as claimed in claim 1, wherein R6 is a C1-C5 alkyl, C2-C5 alkenyl or C2-C5 alkynyl group substituted with one or two substituents independently selected
from —CN; —NO2; —N3; —NH2; —NHRβ; —N(Rβ)2; —NH—CHO; —NRβ—CHO; —NH—CORβ; —NRβ—CORβ; —CONH2; —CONHRβ; or —CON(Rβ)2;
wherein the C1-C5 alkyl, C2-C5 alkenyl or C2-C5 alkynyl group may optionally be further substituted with one or two substituents independently selected from halo; —OH; —ORβ; or oxo (═O); and
wherein each —Rβ is independently selected from a C1-C4 alkyl, C2-C4 alkenyl or C2-C4 alkynyl group, and wherein any —Rβ may optionally be substituted with one or more halo; —OH; —NH2; —CN; —NO2; —N3; or oxo (═O).